BioSpace News Archive

Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced that company management will participate in a fireside chat at the 16th Annual Morgan Stanley Global Healthcare Conference on Wednesday, September 12, 2018 at 1:40 p.m. ET.

AMRI, a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life, and Metrion Biosciences Limited (“Metrion”), the specialist ion channel CRO and drug discovery company, today announced they have signed a new collaboration agreement.

Cantel Medical Corp. (NYSE: CMD), a leading global company dedicated to delivering innovative infection prevention products, services and solutions, announced today that it has recently purchased a new office building at 9800 59th Ave. N. in Plymouth, Minnesota that has capacity for approximately 600 employees.

Livongo Health, the leading consumer digital health company empowering people with chronic conditions to live better and healthier lives, today announced that it will be the first comprehensive offering for people with diabetes to integrate continuous glucose data from Abbott’s FreeStyle® Libre Pro System, a revolutionary continuous glucose monitoring (CGM) system for healthcare professionals.

This year marks ENT and Allergy Associates LLP’s (ENTA) 20-year milestone since its inception.

BioCardia®, Inc. (OTC: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that additional data from the open label, roll-in cohort of the ongoing Phase III CardiAMP™ Heart Failure Trial (CardiAMP-HF Trial) are expected to be presented at three upcoming fall cardiovascular congresses.

Henry Schein One announced today the release of Dentrix® G7, the upgraded version of the award-winning dental practice management system that integrates with the industry’s leading digital imaging solutions to enhance both clinical and financial workflows and improve efficiencies for diagnosis and billing.

Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, today announced that it has appointed Mark Holbrook, PhD, to the newly-created position of vice president of quantitative systems toxicology and safety (QSTS).

Moderna Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Dr. Wellington Sun will join the company as its Head, Vaccine Strategy and Regulatory Affairs, starting later this month.

Gossamer Bio, Inc. (“Gossamer Bio”) today announced that Luisa Salter-Cid, Ph.D. will join its executive management team as Chief Scientific Officer. Dr. Salter-Cid will lead the company’s research and preclinical development efforts.